Company Filing History:
Years Active: 2023
Title: Carina Cantrill: Innovator in Bispecific Antigen Binding Molecules
Introduction
Carina Cantrill is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biochemistry, particularly in the development of bispecific antigen binding molecules. Her innovative work has the potential to impact therapeutic approaches in various medical applications.
Latest Patents
Carina Cantrill holds a patent for "Bispecific antigen binding molecules targeting OX40 and FAP." This invention relates to novel bispecific antigen binding molecules that comprise at least two antigen binding domains capable of specific binding to OX40 and a particular antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP). The patent also covers methods of producing these molecules and methods of using them.
Career Highlights
Carina is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. Her role involves extensive research and development in the field of biopharmaceuticals. With her expertise, she has contributed to advancing the understanding and application of bispecific antibodies.
Collaborations
Throughout her career, Carina has collaborated with notable colleagues, including Maria Amann and Juergen Peter Bachl. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Carina Cantrill's work in bispecific antigen binding molecules exemplifies the intersection of innovation and healthcare. Her contributions are paving the way for new therapeutic strategies that could benefit patients worldwide.